Call for Abstracts or Case Reports for ATS 2022!
We are now accepting abstracts for the ATS 2022 International Conference in San Francisco! Abstracts can report on basic, translational, and clinical science research; epidemiologic, social, biobehavioral, and psychosocial investigations; or educational and quality improvement projects.
Here are some helpful documents to help you get started:
- Criteria, Word Count, and Submission Fee
- Instructions for Submitting an Abstract
- List of Scientific Abstract Classifications
- List of Case Report Classifications
See the full submission criteria, and begin your submission today!
Deadline: 5 p.m. ET, Nov. 3, 2021
AJRCCM Editor Announcement
Congratulations Fernando J. Martinez, MD, MS, the new editor of the prestigious AJRCCM! Dr. Martinez is the Bruce Webster Professor of Medicine and chief of the Division of Pulmonary and Critical Care Medicine of the Joan and Sanford I. Weill Department of Medicine at the Weill Cornell Medical College in New York City. Using translational and clinical science approaches, his work has focused on the biology and therapeutic approaches to COPD and diffuse parenchymal lung diseases. Dr. Martinez succeeds Jadwiga Wedzicha, MD, ATSF. His editorship will begin Jan. 1, 2022.
Medical Associations Create United Front to Reduce Barriers to Noninvasive Ventilation
On July 30, 2021, the journal CHEST® electronically published the outcomes and recommendations of a technical expert panel (TEP) on optimal noninvasive ventilation (NIV), conducted by the American College of Chest Physicians® (CHEST), the American Academy of Sleep Medicine, the American Association for Respiratory Care and the American Thoracic Society.
The CHEST Heath Policy and Advocacy Committee (HPAC) undertook this effort in response to the ongoing and growing concern that lifesaving equipment is being denied payment because of rigid criteria in local coverage determinations and that the existing coverage provided by Centers for Medicare & Medicaid (CMS) is not reflective of rapidly evolving technology in the field. In an effort to remove these regulatory barriers and support coverage of necessary medical equipment, CHEST initiated a patient-focused advocacy initiative for respiratory care called the Optimal NIV Medicare Access Promotion (ONMAP).
Upcoming Events
Virtual International Pediatric Pulmonary Network Clinical Case Series Webinar
Join the ATS Assembly on Pediatrics to discuss, “A 4-Month-Old Girl with Failure to Thrive and Hypoxaemia.”
When: 1:00 p.m. ET, Aug. 5, 2021
Register now.
Assembly on Clinical Problems Journal Club
Join us to discuss, “Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized with Community-Acquired Pneumonia” published in CHEST. (doi: 10.1016/j.chest.2020.06.079).
When: 3 p.m. Aug. 5, 2021
Register now.
Industry Innovations, “Evidence-based use of HFNC: The development of Clinical Practice Guidelines”
The webinar will review the ESICM Clinical Practice Guidelines (Rochwerg, 2020) recently published in Intensive Care Medicine, regarding the use of Nasal High Flow in adult patients.
When: 12 p.m. ET, Aug. 9, 2021
Register now.
Sponsored by Fisher & Paykel
Industry Innovations, “Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes”
In this webinar, faculty will review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD, review their treatment strategies for managing patients with uILD, as well as discuss the clinical implications of new clinical trial findings on the safety and efficacy of emerging treatments in uILD.
When: 6:30 p.m. ET, Aug.18, 2021
Register now.
Sponsored by Genentech, a member of the Roche Group
World's Respiratory Societies Support Community Action and Education for Lung Cancer Awareness Day
In support of World Lung Cancer Day, recognized annually on Aug. 1, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, stresses the importance of community action and early screening to prevent and treat lung cancer.
Responsible for 25 percent of all cancer deaths, lung cancer remains a topic for concern. According to the World Health Organization, each year, more people die of lung cancer than of colon, breast, and liver cancers combined. Worldwide, in 2020, there were 2.21 million new cases of lung cancer and 1.80 million deaths. Despite these alarming statistics, the rate of lung cancer is dropping because of tobacco cessation efforts.
Read more.
